Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1136/jme.2003.006577

Type

Journal article

Journal

J Med Ethics

Publication Date

02/2004

Volume

30

Pages

1 - 7

Keywords

Apotex, Biomedical and Behavioral Research, Hospital for Sick Children (Toronto), University of Toronto, Bioethical Issues, Blood Transfusion, Canada, Clinical Trials as Topic, Deferiprone, Drug Industry, Duty to Warn, Ethics, Research, Humans, Informed Consent, Interinstitutional Relations, Iron Chelating Agents, Liver Cirrhosis, Pyridones, Research Support as Topic, Universities, Whistleblowing, beta-Thalassemia